Technology-supported treatments for prolonged grief (PGD)
Official title: Technology-supported Interventions for Prolonged Grief Disorder in Adults a Randomized Controlled Trial
Run by Universitat Jaume I · NCT06932120 · Data updated 2026-11-12
We will test two internet-based ways of delivering GROw for adults with prolonged grief—one blended with therapist video sessions and one self-guided format supported by app prompts—compared with a waiting list.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 141 (estimated) |
| Sponsor | Universitat Jaume I Academic / other |
| Locations | 2 sites (Castellon, Castellón de La Plana and 1 other locations) |
| Status | Recruiting |
| Started | November 10, 2025 |
| Main results expected | November 10, 2026 |
| Study ends | September 30, 2027 |
| Registry record updated | October 20, 2026 |
| Trial ID | NCT06932120 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) who meet ICD-11 criteria for prolonged grief disorder, can read Spanish, have internet access, an email address and a smartphone, and are not receiving other psychological treatment are ideal candidates.
✕Probably not a fit
People with high suicide risk, severe psychotic, bipolar, severe personality, dementia or substance dependence disorders, those unable to use a computer or smartphone, or those without internet access are unlikely to benefit from these interventions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial will assign adults who meet ICD-11 criteria for prolonged grief disorder to one of three groups: a blended format combining the 8-module GROw program with videoconference therapist sessions (BF-GROw), a self-applied GROw program supported by ecological momentary assessments and interventions via an app (iGROw), or a waiting-list control. Both active arms deliver the same core eight treatment modules and differ in the amount and timing of therapist contact and real-time app support. Primary outcomes are changes in grief symptoms and treatment adherence, with eligibility restricted to Spanish-speaking adults who have internet access and a smartphone. Exclusion criteria include high suicide risk, severe psychiatric or substance use disorders, concurrent psychotherapy, or recent medication changes that would confound results.
Why it matters
Potential benefit: If successful, these formats could make effective grief treatment easier to access and improve symptoms by increasing adherence and providing timely support through video sessions or app-based prompts.
How similar studies have gone: Previous research on internet-based and self-guided interventions for grief and related conditions has shown promise for reducing symptoms and improving access, while blended formats with videoconferencing are less extensively studied but appear promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being at least 18 years old. * Meeting diagnostic criteria for Prolonged Grieft Disorder based on the International Classification of Diseases 11 edition (ICD-11). * Sign an informed consent. * Ability to understand and read Spanish. * Ability to use a computer. * Having an e-mail address. * Having an internet connection and Access to a Smartphone. Exclusion Criteria: * Presence of high risk of suicide. * Presence of axis I severe mental disorder: substance abuse or dependence, psychotic disorder, dementia, bipolar disorder; severe personality disorder or medical illness whose severity or characteristics prevent treatment. * Receiving other psychological treatment during the study. * An increase and/or change in the medication during the study period, in the case of receiving pharmacological treatment.
Where it's running
-
Universitat Jaume I
Castellon, Castellón de La Plana, Spain Recruiting -
Universitat Jaume I
Castellon, Castellón, Spain Not yet recruiting
Study contacts
- Principal investigator: Soledad Quero, Ph.D and psychology — Department of Basic, Clinical Psychology and Psychobiology, Universitat Jaume I, Castellón de la Plana, Spain.
- Study coordinator: Soledad Quero, Ph.D and psychology
- Email: squero@uji.es
- Phone: 964 38 76 41
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Emotion-Focused Therapy for Prolonged Grief Disorder
This trial tests whether Emotion-Focused Therapy helps adults with Prolonged Grief Disorder feel less grief after 8 to 10 weekly therapy sessions or through a self-guided EFT-based program.
-
Short active breaks to boost thinking, creativity, and wellbeing in 11–12-year-olds
This project will see if 10-minute active breaks during the school day help 11–12-year-old children improve attention, working memory, creativity, and emotional wellbeing after demanding classroom tasks.
-
HablaRÉ: self-applied online training to correct emotional reasoning bias for public speaking anxiety
This program will try a self-guided online training to reduce emotional reasoning bias and help adults with public speaking anxiety feel less anxious when speaking in front of others.
-
Using a smartphone app for exposure therapy in anxiety disorders
This study is testing whether using a smartphone app can make exposure therapy more effective for people with anxiety compared to traditional therapy alone.
-
Using STEPPS therapy for patients with Borderline Personality Disorder and their families
This study is testing whether a combined therapy program for people with Borderline Personality Disorder and their families can help them improve more than standard treatments.
-
Blended (online + in-person) versus face-to-face transdiagnostic group therapy for anxiety and depression
This trial will try whether a blended program (online modules plus group sessions) helps adults with anxiety or depression as much as traditional face-to-face group therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.